Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation
| Autor: | Jennifer Furin, GV Yanova, Salmaan Keshavjee, Ann C. Miller, Sidney Atwood, Sonya Shin, I Y Gelmanova, Sergey P. Mishustin |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male Pulmonary and Respiratory Medicine medicine.medical_specialty Tuberculosis Adolescent Alcohol Drinking Treatment outcome Antitubercular Agents Alcohol Logistic regression Article Russia Young Adult chemistry.chemical_compound Risk Factors Internal medicine Tuberculosis Multidrug-Resistant Humans Medicine Adverse effect Aged Retrospective Studies business.industry Middle Aged medicine.disease Logistic Models Treatment Outcome Infectious Diseases chemistry Cohort Female Russian federation business Alcohol consumption |
| Zdroj: | Int J Tuberc Lung Dis |
| ISSN: | 1027-3719 |
| DOI: | 10.5588/ijtld.11.0795 |
| Popis: | SETTING: Alcohol use increases the risk of multidrug-resistant tuberculosis (MDR-TB) and poses challenges for successful MDR-TB treatment, including the potential for additional adverse events. AIM: To investigate the association between alcohol consumption during MDR-TB treatment and adverse events and treatment outcomes in a cohort of patients in Tomsk, Russia. DESIGN: From 2000 to 2004, retrospective data were collected on 407 MDR-TB patients in Tomsk. Factors associated with treatment outcomes were assessed using logistic regression. RESULTS: Of the 407 patients, 253 (62.2%) consumed alcohol during treatment (‘drinkers’), and 367 (90.2%) had at least one documented adverse advent. No significant differences were noted in frequency of adverse events in drinkers vs. non-drinkers. Drinkers had less favourable treatment outcomes (OR 0.28, 95%CI 0.18–0.45). Among drinkers, favourable treatment outcome was associated with adherence to at least 80% of prescribed doses (OR 2.89, 95%CI 1.30–6.43) and the occurrence of an adverse event requiring treatment interruption (OR 2.49, 95%CI 1.11–5.59). CONCLUSIONS: Alcohol use did not appear to increase the risk of adverse events during MDR-TB treatment; however, alcohol consumption was associated with poor outcome. Our findings suggest that individuals who drink alcohol should receive aggressive attention to optimise treatment adherence and manage adverse events. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|